Zolmax Inspire Medical Systems (NYSE:INSP - Get Free Report) had its target price upped by investment analysts at Leerink Partners from $167.00 to $197.00 in a report issued on Tuesday, Benzinga reports...\n more…
Ticker Report Inspire Medical Systems (NYSE:INSP - Get Free Report) had its target price boosted by stock analysts at Leerink Partners from $167.00 to $197.00 in a research report issued to clients and investors...\n more…
Zacks Investment Research Whether you're a growth, value, income, or momentum-focused investor, building a successful investment portfolio takes skill, research, and a little bit of luck.How do you find the right combination...\n more…
Ticker Report Oak Thistle LLC increased its position in Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) by 26.5% in the 2nd quarter, HoldingsChannel reports. The fund owned 1,790 shares of the company's...\n more…
Benzinga Throughout the last three months, 7 analysts have evaluated Inspire Medical Systems INSP, offering a diverse set of opinions from bullish to bearish. The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.\n more…
Ticker Report Van ECK Associates Corp grew its position in shares of Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) by 7.5% in the 2nd quarter, according to the company in its most recent Form 13F filing...\n more…